Recombinant Mouse SLCO1B2 Protein，His

SLCO1B2, a member of the solute carrier organic anion transporter family, plays a crucial role in the hepatic uptake of various endogenous compounds and pharmaceuticals, including statins and anti-cancer drugs. Given its significant influence on drug pharmacokinetics and safety, understanding the function and regulation of SLCO1B2 has become a key focus in both pharmacology and toxicology research. Dysregulation or genetic polymorphisms in SLCO1B2 can lead to altered drug metabolism and interindividual variability in drug response, which may increase the risk of adverse effects or therapeutic failure. Recent advances in recombinant protein technology have enabled researchers to produce and study SLCO1B2 in vitro, facilitating a more detailed examination of its substrate specificity, transport mechanisms, and potential interactions with various inhibitors. Investigating the structural and functional characteristics of SLCO1B2 through reconstitution into artificial membranes provides insights that can aid in predicting drug-drug interactions and optimizing therapeutic regimens. The findings from such studies may ultimately contribute to personalized medicine approaches, informing clinicians about the best drug choices and dosages for individual patients based on their SLCO1B2 genotype and expression levels. Therefore, continuous research on SLCO1B2 recombinant proteins holds promise for enhancing our understanding of drug transport processes and improving clinical outcomes in the management of diseases treated with various pharmacotherapeutics.